Company intelligence / Profile preview

Midwest Medical Isotopes

Oklahoma City, Oklahoma, United Statescmocro.com ↗

Ownership: Private
Development stage: Commercial

Overview

Midwest Medical Isotopes manufactures and supplies FDA-approved injectable radiopharmaceuticals such as ammonia N13, fludeoxyglucose F18, and sodium fluoride F18 for use in PET imaging. The company has developed isotopes used to detect cancers with high precision. Some products may be discontinued but others remain active.

Therapeutic areas: OncologyCardiovascular
Modalities: Radiopharmaceutical
Industry: Metabolite Diagnostics

Partnerships

None publicly disclosed

Beyond the preview

Go deeper on Midwest Medical Isotopes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Midwest Medical Isotopes.

Explore the full profile